Application of two-dimensional gel-based mass spectrometry to functionally dissect resistance to targeted cancer therapy.
about
Annexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A.Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.Seeing through the trick of cancer cells via 2D gels.Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.The role of HIF-1α in chemo-/radioresistant tumors.
P2860
Application of two-dimensional gel-based mass spectrometry to functionally dissect resistance to targeted cancer therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Application of two-dimensional ...... ce to targeted cancer therapy.
@en
Application of two-dimensional ...... ce to targeted cancer therapy.
@nl
type
label
Application of two-dimensional ...... ce to targeted cancer therapy.
@en
Application of two-dimensional ...... ce to targeted cancer therapy.
@nl
prefLabel
Application of two-dimensional ...... ce to targeted cancer therapy.
@en
Application of two-dimensional ...... ce to targeted cancer therapy.
@nl
P2093
P2860
P356
P1476
Application of two-dimensional ...... ce to targeted cancer therapy.
@en
P2093
Joachim Klose
Katja Freitag de Molina
Marion Herrmann
Nadine Rohwer
Oliver Klein
Petra Wessendorf
Stefan Mergler
P2860
P304
P356
10.1002/PRCA.201300056
P577
2013-12-01T00:00:00Z